RPG Life Sciences sets July 3 deadline for FY26 dividend tax documents
RPG Life Sciences Limited has established a July 3, 2026 deadline for shareholders to submit documentation for tax exemptions on the FY26 final dividend of ₹24 per share. The company detailed TDS protocols, including a 10% rate for residents and 20% for non-residents, with specific exemptions available upon submitting valid documents like Form 121 or Tax Residency Certificates.
*this image is generated using AI for illustrative purposes only.
RPG Life Sciences Limited has set a July 3, 2026 deadline for shareholders to submit documentation required for claiming tax exemptions on the final dividend for FY26. The company's Board recommended a dividend of ₹24 per share, subject to shareholder approval, and outlined the tax deduction at source (TDS) protocols that will apply based on the residential status and category of the shareholder.
The company stated that under the Income Tax Act, 2025, the final dividend for FY26 payable in FY27 is taxable in the hands of shareholders. Consequently, RPG Life Sciences will deduct tax at prescribed rates, which vary depending on the shareholder's status and the valid documents submitted. Shareholders are required to ensure their Permanent Account Number (PAN), residential status, and bank details are updated with the depository participant or the registrar, MUFG Intime India Private Limited.
Tax Rates for Resident Shareholders
For resident shareholders, TDS will be deducted at 10% on the dividend amount under Section 393(1) of the Act. However, individuals are exempt from TDS if the aggregate dividend distributed during FY27 does not exceed ₹10,000. The company warned that higher tax rates will apply to shareholders with inoperative PANs or those who have not linked their PAN with Aadhaar.
Specific categories of resident shareholders can claim exemptions from TDS by submitting self-certified documents. These include resident individuals filing Form 121, insurance companies, mutual funds, and Alternative Investment Funds (AIF) established in India. Entities exempt under Section 11 of the Act and corporations established by a Central Act must also provide relevant documentary evidence to avoid TDS.
| Shareholder Category | TDS Rate | Requirement for Exemption |
|---|---|---|
| Resident Individuals | 10% | Form 121 if eligible; exempt if dividend ≤ ₹10,000 |
| Insurance Companies | 10% | Declaration under Section 393(4) |
| Mutual Funds | 10% | Proof of specification under Section 11 and Schedule VII |
| AIF (Category I/II) | 10% | Self-declaration of exemption under Section 11 |
Provisions for Non-Resident Shareholders
Non-resident shareholders face a withholding tax rate of 20%, plus surcharge and cess, unless they opt for benefits under the Double Taxation Avoidance Agreement (DTAA). To avail of DTAA benefits, which may offer more favorable rates, non-residents must provide a Tax Residency Certificate (TRC), e-filed Form 41, and a self-declaration of no taxable presence in India.
The company clarified that it retains sole discretion regarding the application of beneficial DTAA rates based on its review of the submitted documents. Foreign Institutional Investors (FII) and Foreign Portfolio Investors (FPI) will be subject to the 20% rate or the applicable DTAA rate, whichever is more beneficial, provided the necessary documentation is submitted.
Submission and Compliance Guidelines
All documents must be submitted to MUFG Intime India Private Limited via post or registered email by July 3, 2026. Shareholders with multiple accounts under different categories should note that the highest applicable tax rate will be considered for their entire holding. The company emphasized that failure to submit the required documents will result in tax deduction at higher rates, and shareholders will need to claim credits or refunds through their income tax returns.
In cases of joint holdings, the first-named shareholder must furnish the requisite documents. The company further stated that any income tax demands arising from misrepresentation or omission of information by the shareholder will be the shareholder's responsibility, including indemnifying the company.
Historical Stock Returns for RPG Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.34% | +0.06% | -10.70% | -4.27% | +0.96% | +405.02% |
How might the strict TDS protocols and documentation requirements impact foreign investor sentiment towards RPG Life Sciences?
Could the high dividend payout of ₹24 per share signal a shift in the company's capital allocation strategy towards returning cash rather than reinvestment?
What are the potential administrative and compliance costs for the company in managing the complex verification of DTAA benefits and residency statuses?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
